Transcranial Magnetic Stimulation (TMS) Treatment for Post-Traumatic Stress
Evaluates novel Transcranial Magnetic Stimulation (TMS) methods for the treatment of post-traumatic stress disorder (PTSD) and depressive symptoms to determine which strategies provide the greatest benefit to patients.
Transcranial Magnetic Stimulation (TMS) is a non-invasive brain stimulation technique FDA-approved for the treatment of major depressive disorder (MDD) and obsessive compulsive disorder (OCD). However, there is growing evidence that a targeted strategy for delivering TMS treatment would yield superior clinical outcomes if it were more tailored to individual neuroanatomy. In this study, we plan to examine whether functional Magnetic Resonance Imaging (fMRI) guided TMS might yield an even greater leap forward in promoting optimal clinical outcomes.
The study provides TMS treatment at no cost to participants; no insurance is required. Participation includes 20 sessions of TMS treatment over the course of 7 weeks, clinical interviews with study staff, one fMRI scan, and monthly follow-up phone calls for 6 months post-treatment.
Compensation for the fMRI visit is provided.
- Study Identifier: 826007